$4.12B
$967,000
0.0% of portfolio
20,909
Q2 2025
Reduced 36.25%
$1.55B
$2 Million
0.0% of portfolio
223,243
Q2 2025
Added 103.94%
Biomarin Pharmaceutical Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 29.2%
$1.03B
$2.43 Million
0.0% of portfolio
112,913
Q2 2025
Reduced 0.29%
$18.6B
$2.77 Million
0.0% of portfolio
22,028
Q2 2025
Added 20.27%
$22.3M
$51,000
0.0% of portfolio
12,749
Q2 2025
Reduced 30.41%
$805M
$413,000
0.0% of portfolio
9,276
Q2 2025
New
$3.98B
$1.27 Million
0.0% of portfolio
22,635
Q2 2025
Reduced 8.46%
$3.25B
$1.72 Million
0.0% of portfolio
26,850
Q2 2025
Added 1.52%
$3.25B
$1.12 Million
0.0% of portfolio
58,329
Q2 2025
Added 33.1%
-
$0
0.0% of portfolio
-
Q2 2025
New
$321M
$44,000
0.0% of portfolio
10,945
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 13.63%
$651M
$38,000
0.0% of portfolio
11,802
Q2 2025
Reduced 81.34%
$7.39B
$1.24 Million
0.0% of portfolio
51,632
Q2 2025
Reduced 11.87%
$597M
$1.47 Million
0.0% of portfolio
170,983
Q2 2025
Reduced 45.48%
$255M
$96,000
0.0% of portfolio
10,035
Q2 2025
New
$7.73B
$3.61 Million
0.0% of portfolio
28,131
Q2 2025
Reduced 60.08%
-
$0
0.0% of portfolio
-
Q2 2025
Added 37.7%
$818M
$354,000
0.0% of portfolio
2,612
Q2 2025
Reduced 90.76%
-
$0
0.0% of portfolio
-
Q3 2024
Added 28.57%
-
$0
0.0% of portfolio
-
Q2 2025
Added 25.45%
$6.45B
$2.8 Million
0.0% of portfolio
87,593
Q2 2025
Added 67.15%
$1.11B
$670,000
0.0% of portfolio
21,040
Q2 2025
Reduced 21.55%
$0
$427,000
0.0% of portfolio
40,667
Q2 2025
New
$535M
$152,000
0.0% of portfolio
12,488
Q2 2025
Reduced 1.55%
$3.66B
$854,000
0.0% of portfolio
18,720
Q2 2025
Reduced 45.1%
$2.56B
$348,000
0.0% of portfolio
7,664
Q2 2025
Added 48.7%
$3.94B
$299,000
0.0% of portfolio
15,927
Q2 2025
Added 0.08%
$570M
$727,000
0.0% of portfolio
17,937
Q2 2025
Added 33.65%
$9.62B
$4.12 Million
0.0% of portfolio
134,308
Q2 2025
Added 31.65%
$694M
$233,000
0.0% of portfolio
13,599
Q2 2025
Reduced 89.01%
$66.1B
$977,000
0.0% of portfolio
13,806
Q2 2025
New
$34.5B
$2.05 Million
0.0% of portfolio
65,217
Q2 2025
Added 32.27%
Canadian Pacific Kansas City
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 18.23%
$1.43B
$632,000
0.0% of portfolio
30,338
Q2 2025
Added 56.12%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
New
Capital Grp Fixed Incm ETF T
-
$0
0.0% of portfolio
-
Q2 2025
Added 1,552.31%
Capital Grp Fixed Incm ETF T
-
$0
0.0% of portfolio
-
Q2 2025
New
Capital Grp Fixed Incm ETF T
-
$0
0.0% of portfolio
-
Q2 2025
New
Capital Grp Fixed Incm ETF T
-
$0
0.0% of portfolio
-
Q2 2025
New
Capital Group Dividend Growe
-
$0
0.0% of portfolio
-
Q2 2025
Added 2,931.95%
Capital Group Equity ETF Tr
-
$0
0.0% of portfolio
-
Q2 2025
Added 1,613.32%
$844M
$927,000
0.0% of portfolio
152,058
Q2 2025
Added 29.59%
$666M
$2.2 Million
0.0% of portfolio
112,493
Q2 2025
Added 1.33%
$35.4B
$3.6 Million
0.0% of portfolio
141,236
Q2 2025
Reduced 9.95%
$876M
$1.79 Million
0.0% of portfolio
151,461
Q2 2025
Reduced 22.29%
$949M
$3.2 Million
0.0% of portfolio
106,112
Q2 2025
Added 9.88%
-
$0
0.0% of portfolio
-
Q2 2025
New